Fabry
Showing 1 - 25 of 263
Fabry Disease Trial in Bron, Lyon (T1 mapping measurement)
Not yet recruiting
- Fabry Disease
- T1 mapping measurement
-
Bron, France
- +1 more
Jun 27, 2023
Assess Urine Biomarkers to Predict Nephropathy in Fabry Disease
Recruiting
- Fabry Disease
-
Rockville, Maryland
- +1 more
Sep 29, 2023
Fabry Disease Trial in Taipei
Recruiting
- Fabry Disease
-
Taipei, TaiwanInvestigational Site Number :1580001
Sep 24, 2023
Autoimmune and Inflammatory Response Biomarkers in Fabry Disease
Recruiting
- Fabry Disease
-
Madrid, SpainHospital Universitario Ramón y Cajal
Aug 18, 2023
Fabry Disease Trial in Seoul (Fabagal® (Agalsidase beta), Active comparator (Agalsidase beta))
Recruiting
- Fabry Disease
- Fabagal® (Agalsidase beta)
- Active comparator (Agalsidase beta)
-
Seoul, Songpa-gu, Korea, Republic ofSeoul Asan Center
Oct 10, 2023
Based on Electronic Health RecOrds to Identify Patients at
Not yet recruiting
- Fabry Disease
- (no location specified)
Dec 20, 2022
Cardiac Imaging Diagnostic Assay for Monitoring Fabry Disease
Not yet recruiting
- Fabry Disease
- Agalsidase beta
- (no location specified)
Jan 30, 2023
Fabry Disease Trial (Dapagliflozin 10mg Tab, Placebo)
Not yet recruiting
- Fabry Disease
- Dapagliflozin 10mg Tab
- Placebo
- (no location specified)
Jan 23, 2023
Choices Through the Eyes of the Patients
Not yet recruiting
- Fabry Disease
- This is a non-interventional study
-
Eagan, MinnesotaEngage Health
Jan 30, 2023
Fabry Disease Trial in Roma (Sample blood and 2D-echocardiography with Doppler)
Recruiting
- Fabry Disease
- Sample blood and 2D-echocardiography with Doppler
-
Roma, ItalyFondazione Policlinico Gemelli
Feb 27, 2023
Cardiovasculorenal Phenotyping in Fabry Disease Through
Not yet recruiting
- Fabry Disease
- Measures of arterial stiffness and endothelial function
- +3 more
- (no location specified)
Jan 24, 2023
Fabry Disease Trial in Buenos Aires (Recombinant human alpha galactosidase A (agalsidase beta), Recombinant human
Recruiting
- Fabry Disease
- Recombinant human alpha galactosidase A (agalsidase beta)
- Recombinant human alpha-galactosidase A (agalsidase beta)
-
Buenos Aires, ArgentinaInstituto de Investigaciones Clínicas Quilmes
Apr 24, 2023
Fabry Disease in Portuguese Idiopathic Cardiomyopathies
Recruiting
- Fabry Disease
- Alfa-galactosidase activity and genetic testing for Fabry diagnosis
-
Porto, PortugalCentro Hospitalar Universitário São João
Jan 12, 2023
Pain and Quality of Life of Patients With Fabry Disease
Recruiting
- Fabry Disease
-
Seoul, Korea, Republic ofDivision of Cardiology, Yonsei Cardiovascular Hospital, Yonsei U
Jan 18, 2023
Fabry Disease Trial in Melbourne, Perth, Taipei (4D-310)
Active, not recruiting
- Fabry Disease
- 4D-310
-
Melbourne, Australia
- +2 more
Jan 30, 2023
Fabry Disease Trial (PRX-102 1 mg/kg every 2 weeks, PRX-102 2 mg/kg every 4 weeks)
Not yet recruiting
- Fabry Disease
- PRX-102 1 mg/kg every 2 weeks
- PRX-102 2 mg/kg every 4 weeks
- (no location specified)
Jan 24, 2023
Early Detection of Fabry Disease
Not yet recruiting
- Fabry Disease
- No intervention
-
Erlangen, Germany
- +2 more
Sep 30, 2022
Fabry Exercise Intolerance Study
Recruiting
- Fabry Disease
- Fabry Disease, Cardiac Variant
- Intermittent cardiopulmonary exercise test
- Incremental cardiopulmonary exercise test
-
Amsterdam, NetherlandsAmsterdam UMC, location AMC
Jun 9, 2022
Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal
Recruiting
- Fabry Disease
-
Minneapolis, Minnesota
- +1 more
Sep 16, 2022
Fabry Disease and Their Infants During Pregnancy and
Recruiting
- Fabry Disease
-
Philadelphia, PennsylvaniaAmicus Therapeutics, Inc. Pregnancy Registry
Jul 18, 2022
Evaluation of HEArt invoLvement in Patients With FABRY Disease
Recruiting
- Rare Diseases
- +3 more
-
Würzburg, Bayern, GermanyWuerzburg University Hospital
Jul 6, 2022
Fabry Disease Trial in India (Replagal)
Recruiting
- Fabry Disease
- Replagal
-
Hyderabad, India
- +4 more
Nov 2, 2022
